Live GMP
Aureate Tradde Ltd GMP ₹0 SMR Jewels Ltd GMP ₹0 Rajnandini Fashion India Ltd GMP ₹11+17.46% Hexagon Nutrition Ltd GMP ₹3+6.67% Genxai Analytics Ltd GMP ₹0 Vahh Chemicals Ltd GMP ₹0 CMR Green Technologies Ltd GMP ₹0 Merritronix Ltd GMP ₹93+62.42% Liotech Industries Ltd. GMP ₹0
Lenskart Solutions Ltd Logo

Lenskart Solutions Ltd IPO

Closed Bookbuilding IPO NSE & BSE Fresh Capital-cum-Offer for Sale
← Back to GMP
Issue Price ₹402
GMP +₹60
Est. Listing ₹462 (+15%)
Lot Size 37
Face Value ₹2
Issue Size 181,045,160 shares (aggregating up to ₹7,278 Cr)
Subscription

IPO Timeline

Open Date31-Oct-25
Close Date4-Nov-25
Allotment6-Nov-25
Refund Initiation7-Nov-25
Demat Credit7-Nov-25
UPI Mandate Deadline4-Nov-25
Listing Date10-Nov-25
Lock-in (30%)6-Dec-25
Lock-in (50%)4-Feb-26

Category-wise Subscription

Shares offered, bid & amount
CategorySub (x)OfferedBid ForAmt (Cr)*
QIB 135,490,136 (75%) ₹544,670 Cr
NII (HNI) 27,098,027 (15%) ₹108,934 Cr
Retail 18,065,352 (10%) ₹7,262 Cr
Employee 391,645 (0%) ₹157 Cr
Σ  Total181,045,160 (100%)₹7,278,015 Cr

Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.

Issue Details

Issue Price / Price Band₹402
Face Value₹2
Lot Size37 shares
Issue Size181,045,160 shares (aggregating up to ₹7,278 Cr)
Issue TypeBookbuilding IPO
Listing ExchangeNSE & BSE
Sale TypeFresh Capital-cum-Offer for Sale
Script Code
Fresh Issue53,482,587 shares (aggregating up to ₹2,150 Cr)
Offer for Sale127,562,573 shares of ₹2 (aggregating up to ₹5,128 Cr)
Net Offer to Public
Amount In₹ Crore
Stock Price History · BSE
Loading chart data...
H
L
O
Yahoo Finance · Live

Minimum Investment (Lot-wise)

CategoryLotsSharesAmount (₹)
Retail (Min)137₹14,874
Retail (Max)13481₹193,362
S-HNI (Min)14518₹208,236
B-HNI (Min)672,479₹996,558
Retail1 lot(s)37 shares₹14,874
S-HNI68 lot(s)2,516 shares₹1,011,432

Shareholding Pattern

Pre-Issue Shareholding1,681,015,590 shares%
Post-Issue Shareholding1,734,498,177 shares%
Reserved for Market Maker

Financial Statements Amount in ₹ Crore

Metric 30 Jun 2025 31 Mar 2025 31 Mar 2024
Revenue 1,946 7,009 5,610
EBITDA 337 971 672
Profit After Tax 61 297 -10
Net Worth 6,177 6,108 5,642
Total Assets 10,846 10,471 9,531
Reserves & Surplus 5,855 5,795 5,467
Total Borrowing 335 346 497

Valuation & Key Ratios

ROE
ROCE14%
RONW5%
PAT Margin
EBITDA Margin15%
Debt/Equity
P/BV11
Pre EPS₹2
Post EPS₹1
Pre P/E227
Post P/E285

Grey Market Premium (GMP)

+₹60 Current GMP
₹462 Est. Listing Price
+15% Expected Gain

GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.

Objects of the Issue

  • Capital expenditure towards set-up of new CoCo stores in India – 272.62
  • Expenditure for lease/rent/license agreements related payments for our CoCo stores operated by the Company, in India – 591.44
  • Investing in technology and cloud infrastructure – 213.38
  • Brand marketing and business promotion expenses for enhancing brand awareness – 320.06
  • Unidentified inorganic acquisitions and general corporate purposes –

Company Overview

Lenskart Solutions Ltd., established in 2008, is a technology-focused eyewear company involved in the design, manufacturing, branding, and retail of prescription eyeglasses, sunglasses, contact lenses, and accessories. India serves as its primary market, and as per the Redseer Report, the company recorded the highest volume of prescription eyeglasses sold in India during FY 2025.

Operating under a direct-to-consumer model, the company offers a broad range of eyewear under its own brands and sub-brands, catering to all age groups and price segments. In FY 2025, 105 new collections were launched, including collaborations with well-known brands and personalities.

As of March 31, 2025, Lenskart operated 2,723 stores globally—2,067 in India and 656 overseas—with 1,757 owned and 310 franchised stores in India. Remote eye testing is offered through 136 optometrists at 168 stores across India and select international locations, including Japan and Thailand.

Manufacturing is centralized in Bhiwadi and Gurugram, supported by regional facilities in Singapore and the UAE. This setup enables next-day delivery in 40 Indian cities and 3-day delivery in 69 cities for single-vision prescription eyewear.

The company posted revenues of ₹37,880.28 million, ₹54,277.03 million, and ₹66,525.17 million in FY 2023, 2024, and 2025 respectively, showing consistent year-on-year growth. Its apps have over 100 million cumulative downloads, with a tech team of 532 members.

Key strengths include:

  • Centralized supply chain and in-house manufacturing
  • In-house frame and lens engineering
  • Direct-to-consumer approach
  • Customer-centric product design
  • Owned eyewear brand portfolio
  • Technology-led operations and retail experience
  • Omnichannel retail presence
  • Multi-year revenue and EBITDA growth trajectory

Company Information

AddressPlot No. 151, Okhla Industrial Estate Phase III Delhi, New Delhi, 110020